16 research outputs found
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Get PDFElevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma
No full text
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
No full text
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.
No full textMembrane-Bound TNF Supports Secondary Lymphoid Organ Structure but Is Subservient to Secreted TNF in Driving Autoimmune Inflammation
No full textAdditional file 3: Table S2. of A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma
No full textFEV1 at Week 36 (all patients and biomarker subgroups). (XLSX 48Â kb
